Článek v časopise Publikováno 2012

Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer

W. E. Pierceall, K. M. Sprott, T. Heikkinen, P. Heikkila, L. Alaparthi, K. Aittomaki, M. Al-Adhami, V. Villegas-Bergazzi, J. L. Meyer, J. L. Kutok, Jiřina Bartkova, Jiří Bártek, H. Nevanlinna, D. Weaver, C. Blomqvist

Human Pathology 43(9), 1363-1375 (2012)

Zobrazit v PubMed Citovat

2012 Rok
22204715 PMID

Citace publikace

PIERCEALL, W., K. SPROTT, T. HEIKKINEN, P. HEIKKILA, L. ALAPARTHI, K. AITTOMAKI, M. AL-ADHAMI, V. VILLEGAS-BERGAZZI, J. MEYER, J. KUTOK, J. BARTKOVA, J. BÁRTEK, H. NEVANLINNA, D. WEAVER, C. BLOMQVIST: Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer. Human Pathology. 2012, 43(9), 1363-1375, ISSN: 0046-8177, PMID: 22204715.

Citace publikace

Podrobnosti